EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 30 svibnja 2024. Database contains 4917 unique substances/entries.
Filter the list

 
203-770-8
110-46-3
Flam. Liq. 2; Acute Tox. 4
Details
SQ 26999
412-170-7
83623-61-4
STOT RE 2; Eye Dam. 1; Skin Sens. 1
Details
430-460-1
133636-82-5
Skin Corr. 1B; Skin Sens. 1
Details
606-373-1
197706-50-6
Skin Sens. 1
Details
432-360-3
105813-13-6
Acute Tox. 4; Skin Sens. 1
Details
BRL 29226
406-030-4
105812-81-5
Acute Tox. 4; Eye Dam. 1
Details
214-619-0
1166-46-7
Carc. 2; Acute Tox. 4; STOT SE 2
Details
KELCOR; LIPOKEL; SEQUOL
425-230-2
16610-63-2
Skin Corr. 1B
Details
256-032-2
42978-66-5
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
Details
444-480-3
676125-00-1
Skin Irrit. 2
Details
-
115850-69-6
Repr. 1B; Acute Tox. 4; STOT RE 2
Details
-
115937-89-8
Repr. 1B; Acute Tox. 4; STOT RE 2
Details
-
95342-41-9
END Endocrine disrupting properties (Article 57(f) - human health)
Details
427-580-1
211299-54-6
Skin Irrit. 2
Details
-
852541-21-0
END Endocrine disrupting properties (Article 57(f) - human health)
Details
-
741687-98-9
END Endocrine disrupting properties (Article 57(f) - human health)
Details
1418U90
418-530-1
79200-56-9
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
Details
CP-84,203-4; DFX-5S
411-000-9
125224-62-6
Skin Sens. 1
Details
-
135821-03-3
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
-
135821-74-8
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
-
852541-30-1
END Endocrine disrupting properties (Article 57(f) - human health)
Details
P-NITROBENZYLESTER PGSO
412-670-5
54275-93-3
Resp. Sens. 1
Details
-
852541-25-4
END Endocrine disrupting properties (Article 57(f) - human health)
Details
G-EXOMETHYLENE SULFOXIDE ESTER
412-800-0
76109-32-5
Resp. Sens. 1
Details
426-200-1
172015-79-1
STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
Details
SERTRALINE STEP 2
420-560-3
79617-97-3
Eye Dam. 1
Details
220-384-5
2746-19-2
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
Details
CP-141,845-27
426-740-8
256369-40-1
Acute Tox. 4; Eye Dam. 1
Details
BLUE 10 25 964
407-240-9
159604-94-1
Skin Sens. 1
Details
443-840-7
4084-38-2
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
Details
439-360-2
142877-45-0
Skin Irrit. 2; Eye Dam. 1
Details
430-620-0
76145-91-0
STOT RE 2; Skin Sens. 1
Details
433-520-5
82911-69-1
Acute Tox. 4; Skin Sens. 1
Details
430-910-7
13335-71-2
Acute Tox. 4; Eye Dam. 1
Details
DWS
404-940-6
86608-70-0
Acute Tox. 4; Eye Dam. 1; STOT RE 2
Details
X-17-17
417-410-4
61807-67-8
Acute Tox. 4; Skin Corr. 1A; Skin Sens. 1
Details
BUTAMINONITRODARONE; SR33581
444-800-1
141645-23-0
Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
CLETOPROPAMINHYDROCHLORID
429-740-6
40722-80-3
Carc. 1B; Muta. 1B; STOT RE 2; Skin Sens. 1
Details
284-351-7
84852-39-1
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
287-470-2
85508-45-8
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
440-620-2
920-36-5
Water-react. 1; Pyr. Liq. 1; Skin Corr. 1A; STOT SE 3
Details
-
166900-80-7
Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
Details
604-377-8
14371-10-9
Skin Sens. 1A
Details
420-370-0
6485-67-2
Eye Irrit. 2; Skin Sens. 1
Details
-
75166-31-3
R Toxic for reproduction (article 57c)
Details
236-232-6
13250-12-9
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
Details
UK-103,449-BV
427-100-0
-
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
Details
433-820-6
118058-74-5
Eye Irrit. 2
Details
4-AA; AOSA; AZETIDONE-KANEKA; GR91990X
408-050-9
76855-69-1
Eye Irrit. 2; Skin Sens. 1
Details
425-260-6
244634-31-9
STOT RE 2; Eye Dam. 1; Skin Sens. 1
Details
201-501-9
83-79-4
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
822-682-6
1417782-03-6
Skin Sens. 1
Details
-
75166-30-2
R Toxic for reproduction (article 57c)
Details
443-560-5
88784-33-2
Eye Irrit. 2
Details
208-164-7
513-49-5
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
Details
427-200-4
76646-91-8
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
CIN 10094329; SENSIBILISATOR KF 693 PINA; SENSITIZER KF 693 PINA
422-240-9
166596-68-5
Eye Dam. 1; Skin Sens. 1
Details
265-294-7
64969-36-4
Carc. 1B; Acute Tox. 4
Details
428-230-0
79568-06-2
STOT RE 2
Details
222-048-3
3327-22-8
Carc. 2
Details
T 1569; T001569
423-290-4
66938-41-8
Muta. 2
Details
701-394-3
1782069-81-1
END Endocrine disrupting properties (Article 57(f) - human health)
Details
420-380-5
136465-81-1
Acute Tox. 4; Eye Dam. 1
Details
444-350-6
133413-70-4
Eye Irrit. 2
Details
PTH-AA
430-230-0
136522-17-3
Acute Tox. 4
Details
17-KETOBROMOHYDRINE
419-790-7
4229-69-0
Skin Sens. 1
Details
PHOTOAMORCEUR 22074; RHODORSIL PHOTOINITIATOR 2074; TEPBI
422-960-3
178233-72-2
Acute Tox. 4; STOT RE 2
Details
SULPHONAMIDO-ANILINE
406-010-5
88918-84-7
Eye Dam. 1; Skin Sens. 1
Details
247-162-0
25646-77-9
Acute Tox. 3; STOT RE 2; Skin Sens. 1
Details
SILANEOPHAN
405-020-7
105024-66-6
Repr. 1B
Details
SULPHAZINE
406-090-1
81880-96-8
Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1
Details
420-450-5
86552-32-1
Carc. 2; Eye Dam. 1
Details
428-690-2
1668-86-6
Acute Tox. 4; Eye Irrit. 2
Details
425-930-8
151213-39-7
Skin Corr. 1B; Acute Tox. 4; STOT RE 2
Details
692-456-8
688046-61-9
Carc. 2
Details
2691; CARTASOL BRILLANT SCHARLACH K-2GL KONZ.; CARTASOL BRILLANTSCHARLACH K-2GL FLÜSSIG (ZUBEREITUNG); CARTASOL BRILLANTSCHARLACH K-2GL GRANULAT (ZUBEREITUNG); CARTASOL BRILLIANT SCARLET K-2GL; CARTASOL BRILLIANT SCARLET K-2GL CONC.
402-060-7
108225-03-2
Carc. 1B; Eye Dam. 1
Details
423-260-0
100988-63-4
Muta. 2; Skin Sens. 1
Details
433-490-3
6563-83-3
Skin Sens. 1
Details
E.M.A.
406-790-7
26116-56-3
Eye Dam. 1
Details
244-445-0
21564-17-0
Acute Tox. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
(2-BENZOTHIAZOLYLTHIO)BERNSTEINSÄURE; BTTBS; HALOX 650; IRGACOR 252
401-450-4
95154-01-1
Skin Sens. 1
Details
OA 8523
402-460-1
-
Skin Irrit. 2; Skin Sens. 1
Details
616-221-6
7541-49-3
Skin Irrit. 2
Details
204-647-1
123-73-9
Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Details
227-678-2
5932-68-3
Skin Sens. 1A
Details
HEXAROSE
421-370-3
3681-73-0
Skin Irrit. 2
Details
DPP
410-980-5
112704-51-5
Eye Irrit. 2; Skin Sens. 1
Details
PYRIDYLACROLEIN
426-330-9
177964-68-0
Eye Irrit. 2; Skin Sens. 1
Details
CP-166,221
428-010-4
82413-20-5
Carc. 2; Repr. 1B; Skin Sens. 1
Details
429-900-5
101151-17-1
Skin Sens. 1
Details
210-855-3
624-64-6
Flam. Gas 1; Press. Gas
Details
NCC ETHER
406-100-4
94097-88-8
Skin Sens. 1
Details
423-240-1
125474-34-2
Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
MEXORYL SX; SX 32
410-960-6
92761-26-7
Eye Dam. 1
Details
TFA-4713
418-960-8
-
Skin Corr. 1B; Skin Sens. 1
Details
AOC 1020X
402-370-2
149057-70-5
Flam. Liq. 3; Eye Dam. 1
Details
284-348-0
84852-36-8
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
285-909-2
85166-19-4
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
287-471-8
85508-46-9
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details
287-592-6
85551-28-6
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
Details

Export search results to: